References
- Kaló Z, Alabbadi I, Al Ahdab OG, et al. Implications of external price referencing of pharmaceuticals in Middle East countries. Expert Rev Pharmacoecon Outcomes Res. 2015;15(6):993–998.
- Puig-Junoy J. What is required to evaluate the impact of pharmaceutical reference pricing? Appl Health Econ Health Policy. 2005;4(2):87–98.
- Allison P. When Can You Safely Ignore Multicollinearity? | Statistical Horizons. [ Published 2012 Sep 10; cited 2015 Nov 10]. Available from: http://statisticalhorizons.com/multicollinearity.
- Nosek BA, Alter G, Banks GC, et al. Promoting an open research culture. Science. 2015;348(6242):1422–1425.
- MedlinePlus - Health Information from the National Library of Medicine. [ cited 2015 Nov 13]. Available from: https://www.nlm.nih.gov/medlineplus/.